Evidence map›Paper›PMID 8564078›Full record

ArticleIn vitro cellular & developmental biology. Animal1995

Heparin and the phenotype of adult human vascular smooth muscle cells.

T Sorger, N Friday, L D Yang, E M Levine

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

T SorgerWistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104, USA.
N Friday
L D Yang
E M Levine
The Wistar Institute · US

Funding

STUDIES OF HUMAN ENDOTHELIAL CELLS OF DIVERSE ORIGINP01AG004861 · NIA · WISTAR INSTITUTE · PI LEVINE, ELLIOT M · 1986 to 1990
–
PROLIFERATION AND FUNCTION IN HUMAN ENDOTHELIAL CELLSR01HL034153 · NHLBI · WISTAR INSTITUTE · PI LEVINE, ELLIOT M · 1986 to 1990
–
NHLBI NIH HHS HL-34153NIA NIH HHS AG-04861
6 · The paper itself

Abstract

To study mechanisms controlling growth and phenotype in human vascular smooth muscle cells, we established culture conditions under which these cells proliferate rapidly and achieve life-spans of 50-60 population doublings. In medium containing heparin and heparin-binding growth factors, growth rate and life-span of human vascular smooth muscle cells increased more than 50% relative to cultures with neither supplement, and more than 20% compared to cultures supplemented only with heparin-binding growth factors. In contrast to observations made in rat vascular smooth muscle cells, smooth muscle-specific alpha-actin in the human cells was expressed only in the presence of heparin and colocalized with beta/gamma nonmuscle actins in stress fibers, not in adhesion plaques. Heparin, in the presence of heparin-binding growth factors, also caused more than 170% stimulation of tracer glucosamine incorporation into hyaluronic acid and a 7.5-fold increase in hyaluronic acid accumulation. In comparison, total sulfate incorporation into sulfated glycosaminoglycans increased by less than 40%. In light of our previous findings that heparin suppresses collagen gene expression, we conclude that heparin induces human vascular smooth muscle cells exposed to heparin-binding growth factors to remodel their extracellular matrix by altering the relative rates of hyaluronic acid (HA) and collagen synthesis. The resulting hyaluronic-acid-rich, collagen-poor matrix may enhance infiltration of CD44/hyaluronate-receptor-bearing T-lymphocytes and monocytes into the vascular wall, an early event in atherogenesis.

Indexed as

Cell Culture TechniquesActin CytoskeletonActinsAdultAnimalsBase SequenceCell DivisionCells, CulturedExtracellular MatrixGlycosaminoglycansGrowth SubstancesHeparinHumansHyaluronic AcidMolecular Sequence DataMuscle, Smooth, VascularActinsGlycosaminoglycansGrowth SubstancesHeparinHyaluronic AcidOligonucleotide Probes

Identifiers

PMID8564078
OpenAlexW2080459897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.